로딩 중…
지수 로딩 중…
Aurinia Pharmaceuticals Inc.
AUPH· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CA
CA$16.46+1.98%
2026-06-18
Price Chart
Aurinia Pharmaceuticals Inc.+107.83%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.12B |
| Revenue | $298M |
| Net Income | $298M |
| Total Assets | $724M |
| Net Assets | $568M |
| Value | |
| P/E | 7.10x |
| P/B | 3.73x |
| PEG | 0.15x |
| P/S | 7.10x |
| EV/EBITDA | 13.25x |
| FCF Yield | 7.82% |
| Profitability | |
| ROE | 52.54% |
| ROA | 41.19% |
| Op. Margin | 41.73% |
| Revenue Growth | 24.40% |
| Earnings Growth | 47.17% |
| Financial Health | |
| Debt Ratio | 27.55% |
| Total Debt | $69M |
| FCF | $166M |
| Cash | $41M |
| Current Ratio | 5.55x |
| Net Debt/EBITDA | 0.17x |
| Performance | |
| 1Y Return | 107.83% |
| 1M Return | 5.85% |
| From 52W High | -2.49% |
| 1Y MDD | -15.91% |
| Trading | |
| Volume | 1,135,399 shares |
| Trading Value | $19M |
| Per Share | |
| EPS | $2.14 |
| BPS | $4.33 |